Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD Acute Central Line

K-Number: K190855 · 2019-11-01

Decision Date2019-11-01
Product CodeFOZ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD Acute Central Line is a medical device manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd). It received FDA 510(k) clearance on 2019-11-01 under approval number K190855. The device is classified under product code FOZ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD Acute Central Line?

BD Acute Central Line is a medical device that received FDA 510(k) clearance on 2019-11-01. It is manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd). The 510(k) number is K190855.

When was BD Acute Central Line approved by the FDA?

BD Acute Central Line received FDA 510(k) clearance on 2019-11-01, under approval number K190855.

What company makes BD Acute Central Line?

BD Acute Central Line is manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd).

What is the FDA product code for BD Acute Central Line?

The FDA product code for BD Acute Central Line is FOZ.

Related Clinical Trials

Other Devices by Bard Access Systems, Inc. (Bard Has Joined Bd)

Related Devices (Code: FOZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.